Zebrafish-Based Drug Discovery
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 21712
Special Issue Editor
Interests: zebrafish; pharmacology; obesity; cancer; natural product; chemical screening
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Zebrafish (Danio rerio) is contributing to speeding up drug discovery in a range of areas, including phenotype-based screening using disease models (so-called “zebrafish screening”), target molecule discovery, validation of the results of cell studies before clinical trials, and toxicological evaluation. As a result, many drug candidates, first-in-class drugs, and several drugs for off-label use have been discovered using zebrafish over the past 10 years. This Special Issue provides a forum to discuss zebrafish-based drug discovery from broader perspectives, including the creation of human disease models, technologies harnessing these as model organisms, and their use for drug or drug candidate identification. Review articles by experts in the field are particularly welcome.
Prof. Dr. Yasuhito Shimada
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug screening
- disease model
- obesity
- cancer
- musculoskeletal diseases
- toxicology
- neurological disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.